CymaBay Therapeutics to Present at the 42nd Annual JP Morgan Healthcare Conference 2024

Rhea-AI Summary

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) announces President and CEO Sujal Shah's presentation at the 42nd Annual JP Morgan Healthcare Conference on January 10, 2024, focusing on innovative therapies for liver and chronic diseases.

NEWARK, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that its President and Chief Executive Officer, Sujal Shah, will present at the upcoming 42^nd Annual JP Morgan Healthcare Conference taking place January 8 -11 in San Francisco, California.

42nd Annual JP Morgan Healthcare Conference
Date:			Wednesday, January 10, 2024
Time:			4:30pm PT/ 7:30pm ET
Location:			Grand Ballroom, The Westin St. Francis Hotel, San Francisco
Webcast:			http://ir.cymabay.com/events

About CymaBay
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies. Our deep understanding of the underlying mechanisms of liver inflammation and fibrosis, and the unique targets that play a role in their progression, have helped us receive breakthrough therapy designation (U.S. Food and Drug Administration), Priority Medicines status (European Medicines Agency) and orphan drug status (U.S. and Europe) for seladelpar, a first-in-class investigational treatment for people with PBC. Our evidence-based decision-making and commitment to the highest quality standards reflect our relentless dedication to the people, families, and communities we serve. To learn more, visit www.cymabay.com and follow us on X (formerly Twitter) and LinkedIn.

For additional information about CymaBay visit www.cymabay.com.

Public Relations Contact:                                    

Theresa Dolge
Evoke Kyne
(609) 915-2156
Theresa.Dolge@evokegroup.com

Investor Relations Contact:

PJ Kelleher
LifeSci Advisors, LLC
(617) 430-7579
pkelleher@LifeSciAdvisors.com

What is the date of the 42nd Annual JP Morgan Healthcare Conference where CymaBay Therapeutics, Inc. will present?

The conference will take place on January 8 - 11, 2024.

Where will the presentation by CymaBay Therapeutics, Inc. take place?

The presentation will be held at the Grand Ballroom, The Westin St. Francis Hotel, San Francisco.

What is the webcast link for CymaBay Therapeutics, Inc.'s presentation at the conference?

The webcast link is http://ir.cymabay.com/events.

Who is the President and CEO of CymaBay Therapeutics, Inc.?

Sujal Shah is the President and CEO of CymaBay Therapeutics, Inc.